April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Glaucoma in Keratoplasty: Risk factors, Management and Outcome
Author Affiliations & Notes
  • Anna-Karina B. Maier
    Ophthalmology, Campus Virchow Klinikum, Charite, Berlin, Berlin, Germany
  • Klaudia K. Huber
    Ophthalmology, University of Duesseldorf, Duesseldorf, Germany
  • Matthias K. Klamann
    Ophthalmology, Campus Virchow Klinikum, Charite, Berlin, Berlin, Germany
  • Jessica Rottler
    Ophthalmology, St. Johannes Hospital, Dortmund, Germany
  • Sevil Özlügedik
    Ophthalmology, University of Duesseldorf, Duesseldorf, Germany
  • Sibylle Winterhalter
    Ophthalmology, Campus Virchow Klinikum, Charite, Berlin, Berlin, Germany
  • Katja Rosenbaum
    Ophthalmology, University of Duesseldorf, Duesseldorf, Germany
  • Antonia M. Joussen
    Ophthalmology, Campus Virchow Klinikum, Charite, Berlin, Berlin, Germany
  • Footnotes
    Commercial Relationships  Anna-Karina B. Maier, None; Klaudia K. Huber, None; Matthias K. Klamann, None; Jessica Rottler, None; Sevil Özlügedik, None; Sibylle Winterhalter, None; Katja Rosenbaum, None; Antonia M. Joussen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 366. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anna-Karina B. Maier, Klaudia K. Huber, Matthias K. Klamann, Jessica Rottler, Sevil Özlügedik, Sibylle Winterhalter, Katja Rosenbaum, Antonia M. Joussen; Glaucoma in Keratoplasty: Risk factors, Management and Outcome. Invest. Ophthalmol. Vis. Sci. 2011;52(14):366.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glaucoma is a leading cause for graft failure. This retrospective study analyzes the risk factors, graft status, and treatment modalities in patients with post-penetrating keratoplasty glaucoma.

Methods: : A retrospective analysis of case records of 1848 penetrating keratoplasties, between 2000 and 2005 was performed. A total of 160 patients (160 eyes) with post-penetrating keratoplasty glaucoma were included. The assessment included the pre-operative history of corneal disease and glaucoma, the lens status and the anaesthesiological techniques. Furthermore the response to anti-glaucoma treatment, graft failure, and endothelial cell loss was evaluated.

Results: : The incidence of post-penetrating keratoplasty glaucoma was 8.7% (160/1848). Half of the patients (81 patients) responded to medical therapy (51%), the other half of patients (79 patients) to surgical therapy (49%), whereas filtering surgery, and cyclodestructive procedures were performed. One patient got a glaucoma implant. Clear grafts were achieved in 94 eyes (59%). Visual acuity after 24 months of logMar 1.0 or better was achieved in 77 eyes (46%), of logMar 0.4 in 33 eyes (21%).

Conclusions: : Careful and ongoing observation of intra ocular pressure throughout the prolonged follow-up period is recommended for patients after penetrating keratoplasty and prompt attention to intraocular pressure treatment is indicated. But any anti-glaucoma therapy may not achieve optimum visual outcome, despite a clear graft. Whereas a graft can usually repeated, if the optic nerve is damaged from end-stage glaucoma, useful vision can not be restored.

Keywords: cornea: clinical science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×